sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Biohacking Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030

Biohacking Market Size, Share & Trends Analysis - Global opportunity...

Home / Categories / Other
Biohacking Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030
Biohacking Market Size, Share &...
Report Code
RO13/107/1790

Publish Date
17/Apr/2022

Pages
210
PRICE
$ 4570 /-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5450 /-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7695 /-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

The global biohacking market size was US$ 21.2 billion in 2021. The global biohacking market is forecast to grow to US$ 101.6 billion by 2030 by registering a compound annual growth rate (CAGR) of 19.3% during the forecast period from 2022 to 2030. 

Biohacking is also regarded as do-it-yourself biology. Through biohacking, individuals make small, incremental diet or lifestyle changes to make small improvements in their regular health and well-being. Biohacking is managing an individual’s biology in terms of nutrition. For this, electronic and medical technologies are used to bring a significant change in synthetic biology. 

Factors Influencing the Market

Growing focus on health and fitness is the primary factor driving the demand for biohacking. In addition, trends in smart wearables and home healthcare will contribute to the growth of the global biohacking market during the study period. 

The increasing prevalence of chronic diseases, together with the growing individual spending on healthcare, will drive the market forward. Furthermore, the introduction of novel drugs and increasing demand for implants that improve the capabilities of individual will benefit the biohacking market. 

The high cost associated with the establishment of biohacking labs may limit the growth of the market. On the contrary, other trends in the biohacking market, such as rising awareness about biohacking and growing technological advancements for tracking heart rate, steps, blood sugar level, etc., will amplify the market growth. 

COVID-19 Impact Analysis

The global biohacking market has been positively affected by the COVID-19 pandemic. The pandemic triggered the demand for efficient devices to track heart rate, steps, blood sugar levels, etc., regularly. Moreover, it also upscaled the demand for efficient testing kits, which offered several opportunities for biohacking market growth.

Regional Analysis

North America is forecast to hold the highest share in the biohacking market, owing to the rising prevalence of diseases in the region. Furthermore, other factors, such as growing R&D activities and organizations support, will contribute to the growth of this market during the study period.  

The demand for synthetic biology is witnessing an increase in the region, majorly in the U.S., which will benefit the overall market during the forecast period. 

The Asia-Pacific biohacking market is expected to emerge as the fastest-growing biohacking market, owing to the growing investment by the respective governments and increasing healthcare infrastructure. Furthermore, the extensively growing adoption of smart devices will significantly contribute to the growth of the market during the study period. 

Competitors in the Market

  • Apple Inc.
  • Thync Global Inc.
  • Fitbit, Inc.
  • The ODIN
  • Moodmetric
  • Muse (Interaxon Inc.)
  • Thriveport, LLC
  • TrackMyStack
  • HVMN Inc.
  • OsteoStrong
  • Other Prominent Players

Market Segmentation

The global biohacking market segmentation focuses on Components, Product, Application, End-User, and Region. 

By Component Outlook

  • Solution
  • Services

By Product Outlook

  • Wearables, Implants (Chips)
  • Gene Modification Kits
  • Smart Drugs
  • Supplements
  • Others

By Application Outlook

  • Synthetic Biology
  • Genetic Engineering
  • Forensic Science
  • Diagnosis & Treatment
  • Drug Testing
  • Others

By End-User Outlook

  • Pharmaceutical & Biotechnological Companies
  • Forensic Laboratories
  • Hospitals & Clinics
  • Research & Academic Institutes
  • Others

By Regional Outlook

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Brazil
  • Argentina
  • Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com